<i>In silico</i> Analysis of Interactions between Nevirapine-related Compounds, <i>HLA-B*14:02 </i>and T-cell Receptor<b> </b>

DOI Web Site 1 Citations 9 References

Bibliographic Information

Other Title
  • ネビラピン関連化合物、<i>HLA-B*14:02</i>およびＴ細胞受容体相互作用の<i>in silico</i>解析
  • In silico analysis of interactions between nevirapine-related compounds, HLA-B*14:02 and T-cell Receptor

Abstract

A non-nucleoside reverse-transcriptase inhibitor nevirapine (NVP) used to treat HIV-1 infection can cause severe, life-threatening idiosyncratic drug toxicity (IDT). It is known that the IDT caused by NVP or its metabolites is associated with the HLA-B*14:02 haplotype. The molecular mechanism of the HLA-associated IDT, however, has not been disclosed. In this study, we have simulated the interaction modes between NVP-related compounds, HLA B*14:02, and a T-cell receptor in order to understand the molecular mechanism leading to the onset of IDT.

Journal

Citations (1)*help

See more

References(9)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top